Healthcare marketing is evolving, and policy is a big part of that story. From conversations about drug advertising to new ideas like tariffs on imported medicines, there’s a lot happening that could reshape how the industry communicates with patients and providers.

In this episode, Jim Potter, Executive Director of the Coalition for Healthcare Communication, joins health advertising expert John Mangano to break down the latest proposals and what they might mean in practice, from ad rules and tax policy to efforts to bring more drug manufacturing back to the U.S. You’ll hear why some ideas generate headlines but face big legal and practical hurdles, and how industry groups are preparing for what comes next.

Most importantly, we highlight how smart communication can support better health outcomes and why advertising plays a bigger role than many realize. It’s a thoughtful look at the balance between policy, industry, and patient needs, with abundant insights for anyone curious about where healthcare is headed.